Tracon Pharmaceuticals Inc Expected To Post A Loss Of 28 Cents A Share: Earnings Preview

TRACON Pharmaceuticals

28/10/2022 13:30

* TRACON Pharmaceuticals Inc  TCON.OQ   TCON.O  is expected
to show no change in quarterly revenue when it reports 
results on November 1 (estimated). 
    * 
    * ​Refinitiv's mean analyst estimate for TRACON
Pharmaceuticals
Inc is for a loss of 28 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for TRACON
Pharmaceuticals Inc is $9​, above​ its last closing price
of $1.60. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  REFINITIV  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  IBES                 MET,    SE %
               E®          ESTIMATE             MISSED  
 Jun. 30 2022  -0.36       -0.37      -0.31     Beat    16.8
 Mar. 31 2022  -0.42       -0.42      -0.48     Missed  -15
 Dec. 31 2021  -0.36       -0.35      -0.40     Missed  -13.4​
 Sep. 30 2021  -0.32       -0.32      -0.38     Missed  -17.2
 ​​Jun.        -0.32       -0.31      -0.58     Missed  -86.2
 30 2021                                                
 Mar. 31 2021  -0.30       -0.30      -0.33     Missed  -8.2​
 Dec. 31 2020  -0.44       -0.41      -0.31     Beat    23.6
 Sep. 30 2020  -0.64       -0.65      -0.38     Beat    41.5
 This summary was machine generated October 28 at 12:30 GMT.  All
figures in US dollars  unless otherwise stated